Your browser doesn't support javascript.
loading
Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort.
Quintana, Rosana; Pons-Estel, Guillermo J; Roberts, Karen; Sacnún, Mónica; Serrano, Rosa; Nieto, Romina; Conti, Silvana; Gervasoni, Viviana; Catoggio, Luis J; Soriano, Enrique R; Scolnik, Marina; García, Mercedes A; Alvarellos, Alejandro; Saurit, Verónica; Berbotto, Guillermo A; Sato, Emilia I; Costallat, Lilian T Lavras; Neto, Eduardo Ferreira Borba; Bonfa, Eloisa; Xavier, Ricardo M; de Oliveira E Silva Montandon, Ana Carolina; Molina-Restrepo, José Fernando; Iglesias-Gamarra, Antonio; Guibert-Toledano, Marlene; Reyes-Llerena, Gil Alberto; Massardo, Loreto; Neira, Oscar J; Cardiel, Mario H; Barile-Fabris, Leonor A; Amigo, Mary-Carmen; Silveira, Luis H; Torre, Ignacio García De La; Acevedo-Vásquez, Eduardo M; Ugarte-Gil, Manuel F; Alfaro-Lozano, José Luis; Segami, María Inés; Chacón-Díaz, Rosa; Esteva-Spinetti, María H; Gomez-Puerta, José A; Alarcón, Graciela S; Pons-Estel, Bernardo A.
Afiliação
  • Quintana R; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
  • Pons-Estel GJ; Hospital Provincial de Rosario, Rosario, Argentina.
  • Roberts K; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
  • Sacnún M; Hospital Provincial de Rosario, Rosario, Argentina.
  • Serrano R; Hospital Provincial de Rosario, Rosario, Argentina.
  • Nieto R; Hospital Provincial de Rosario, Rosario, Argentina.
  • Conti S; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
  • Gervasoni V; Hospital Provincial de Rosario, Rosario, Argentina.
  • Catoggio LJ; Hospital Provincial de Rosario, Rosario, Argentina.
  • Soriano ER; Hospital Provincial de Rosario, Rosario, Argentina.
  • Scolnik M; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • García MA; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Alvarellos A; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Saurit V; Hospital Interzonal General de Agudos General San Martín, La Plata, Argentina.
  • Berbotto GA; Hospital Privado, Centro Médico de Córdoba, Córdoba.
  • Sato EI; Hospital Privado, Centro Médico de Córdoba, Córdoba.
  • Costallat LTL; Hospital Escuela Eva Perón, Granadero Baigorria, Argentina.
  • Neto EFB; Universidade Federal da Sao Paulo (UNIFESP), Sao Paulo, Brazil.
  • Bonfa E; Universidade Estadual da Campinas, Campinas, Brazil.
  • Xavier RM; Universidade da Sao Paulo, Sao Paulo, Brazil.
  • de Oliveira E Silva Montandon AC; Universidade da Sao Paulo, Sao Paulo, Brazil.
  • Molina-Restrepo JF; Hospital da Clinicas da Porto Alegre, Universidade Federal do Rio Grande do Sul, Brazil.
  • Iglesias-Gamarra A; Faculdade de Medicina, Universidade Federal de Goias, Goiania, Brazil.
  • Guibert-Toledano M; Centro Integral de Reumatología, Reumalab, Medellín, Colombia.
  • Reyes-Llerena GA; Hospital Santa Rosa Bogotá, Universidad Nacional, Bogotá, Colombia.
  • Massardo L; Centro de Investigaciones Médico Quirúrgicas (CIMEQ), La Habana, Cuba.
  • Neira OJ; Centro de Investigaciones Médico Quirúrgicas (CIMEQ), La Habana, Cuba.
  • Cardiel MH; Facultad de Medicina, Universidad San Sebastián, Santiago, Chile.
  • Barile-Fabris LA; Hospital del Salvador, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
  • Amigo MC; Centro de Investigación Clínica de Morelia SC, Morelia, Mexico.
  • Silveira LH; Hospital Ángeles del Pedregal, Ciudad de México, Mexico.
  • Torre IG; Centro Médico ABC, Ciudad de México, Mexico.
  • Acevedo-Vásquez EM; Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico.
  • Ugarte-Gil MF; Hospital General de Occidente de la Secretaría de Salud, Guadalajara, Mexico.
  • Alfaro-Lozano JL; Servicio de Reumatología, Hospital General Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.
  • Segami MI; Servicio de Reumatología, Hospital General Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.
  • Chacón-Díaz R; Universidad Científica del Sur, Lima, Peru.
  • Esteva-Spinetti MH; Servicio de Reumatología, Hospital General Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.
  • Gomez-Puerta JA; Hospital Nacional Edgardo Rebagliatti Martins, ESSALUD, Lima, Peru.
  • Alarcón GS; Centro Nacional de Enfermedades Reumáticas, Hospital Universitario de Caracas, Caracas, Venezuela.
  • Pons-Estel BA; Hospital Central de San Cristóbal, San Cristóbal, Venezuela.
Lupus ; 29(9): 1140-1145, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32605527
ABSTRACT

OBJECTIVES:

This study aimed to compare the clinical features, damage accrual, and survival of patients with familial and sporadic systemic lupus erythematosus (SLE).

METHODS:

A multi-ethnic, multinational Latin American SLE cohort was studied. Familial lupus was defined as patients with a first-degree SLE relative; these relatives were interviewed in person or by telephone. Clinical variables, disease activity, damage, and mortality were compared. Odds ratios (OR) and 95% confidence intervals (CI) were estimated. Hazard ratios (HR) were calculated using Cox proportional hazard adjusted for potential confounders for time to damage and mortality.

RESULTS:

A total of 66 (5.6%) patients had familial lupus, and 1110 (94.4%) had sporadic lupus. Both groups were predominantly female, of comparable age, and of similar ethnic distribution. Discoid lupus (OR = 1.97; 95% CI 1.08-3.60) and neurologic disorder (OR = 1.65; 95% CI 1.00-2.73) were significantly associated with familial SLE; pericarditis was negatively associated (OR = 0.35; 95% CI 0.14-0.87). The SLE Disease Activity Index and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) were similar in both groups, although the neuropsychiatric (45.4% vs. 33.5%; p = 0.04) and musculoskeletal (6.1% vs. 1.9%; p = 0.02) domains of the SDI were more frequent in familial lupus. They were not retained in the Cox models (by domains). Familial lupus was not significantly associated with damage accrual (HR = 0.69; 95% CI 0.30-1.55) or mortality (HR = 1.23; 95% CI 0.26-4.81).

CONCLUSION:

Familial SLE is not characterized by a more severe form of disease than sporadic lupus. We also observed that familial SLE has a higher frequency of discoid lupus and neurologic manifestations and a lower frequency of pericarditis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Etnicidade / Lúpus Eritematoso Sistêmico Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Lupus Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Argentina

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Etnicidade / Lúpus Eritematoso Sistêmico Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Lupus Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Argentina